Drugmakers Commit to Reducing Drug Launch Times in the EU
Members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) have pledged to file for pricing and reimbursement in [...]
Pharma’s Top 20 Companies by Revenue in 2021
Several top pharma companies saw massive gains in 2021, with some manufacturer’s drugs hitting record sales. Companies producing COVID-related products [...]
Fierce Healthcare Webinar: Operating as a Learning Health System
Healthcare affordability, quality, outcomes, and patient satisfaction are impacted by inefficiencies in the industry. A compounding factor has been the [...]
Conference: Pharma & Patient 2022
The changing relationship between pharma and patients will be explored at Pharma & Patient 2022 from November 8th-9th in Philadelphia, [...]
Sanofi Launches Industry’s First Diversity, Equity, and Inclusion Board with Outside Advisor
The multinational pharmaceutical corporation Sanofi has launched its new Diversity, Equity, and Inclusion (DE&I) Board, the first of its kind [...]
US Biosimilars Market – 5 Things to Look Out for in 2022
The biosimilars market in the US has ramped up significantly in the past year, amidst rising political pressure surrounding high [...]
UK’s NICE Changes Stance on New Osteoporosis Drug
The novel osteoporosis drug Evenity can be prescribed on the NHS, according to NICE. The move is a reversal of [...]
White Paper: Managing Change Control to Comply with FDA and EU Regulations
International pharma and biotech companies must contend with dynamic market conditions and changes in regulatory bodies’ requirements and guidances. A [...]
Payers Facing Increased Scrutiny in Prescription Drug Pricing Debate
The debate surrounding high prescription drug prices has classically focused on the role of drug manufacturers. However, as frustration builds [...]
FDA Oncology Chief Denies Claims that Rejection of Lilly and Innovent Cancer Drug is Politically Motivated
On the heels of the FDA’s rejection of Eli Lilly and Innovent Biologics’ low-cost lung cancer immunotherapy drug sintilimab, the [...]
2022: Top 10 Drugs Losing Exclusivity
As high-profile drugs like Abbvie’s Humira and Bristol Myers Squibb’s (BSQ) prepare to face increased competition in the form of [...]
Reuters Events: Pharma Clinical 2022
Reuters Events is hosting Pharma Clinical 2022, a virtual meeting where over 500 clinical innovators will collaborate to discuss new [...]
Accelerating Market Access to Medical Advances With Lumanity
Lumanity, a company focused on bringing new therapeutics to patients, has launched today. Despite recent medical advances in drug development [...]
Pharma14 Adds New Zealand Medicine and Pricing Information
Pharma14 has announced that New Zealand is the latest country to be added to its list of over 66 countries [...]
Purdue Pharma’s $6 Billion Settlement for the Opioid Epidemic Approved by Judge
US Bankruptcy Judge Robert Drain has approved the $6 billion bankruptcy settlement for Purdue Pharma and its owners, the [...]
Examining the Canadian Drug Reimbursement Environment
The Canadian market holds many lucrative opportunities for Canadian manufacturers, but standards for approval and reimbursement are markedly different from [...]
Share Your Story About High Drug Prices
At his State of the Union Address last week, President Biden shared the story of a family struggling to pay [...]
Avoiding 5 Pitfalls in Pharma Compliance
Pharma compliance is a tricky process, full of strict requirements. MasterControl’s Regina Fullin details 5 mistakes to avoid to get [...]
7 Takeaways for Pharma from the FDA’s Quality System Guidance
Of all the guidances issued by the FDA, the “Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations,” is [...]
US District Judge Refuses Motion to Drop Eli Lilly Whistleblower Lawsuit
Eli Lilly’s motion to drop a 2014 whistleblower lawsuit surrounding claims it misled the Centers for Medicare and Medicaid Services [...]
Pricing and Competition Regulatory Attempts Chill Mergers and Acquisitions in Pharma
As nations and their regulatory bodies dial up the pressure on drug pricing, pharmaceutical companies have become uneasy regarding mergers [...]
Webinar: Learning from the Pandemic to Accelerate AAV-based Gene Therapies
On Thursday, March 17th, Fierce Biotech and Cytiva present a webinar on applying lessons from the COVID-19 pandemic to accelerate [...]
Projected Market Value for Health Economics and Outcomes Research Services Could Reach $2 Billion by 2028
Analysis by Global Market Insights Inc. indicates that the health economics and outcomes research (HEOR) services market could grow to [...]
Evidence Doesn’t Suggest Cost-Shifting Between Public and Private Prescription Drug Markets
Recent pushes for drug pricing reforms have reignited worries that such a move would drive prescription prices up in the [...]
New GoodRx Report Reveals Price Hikes on Over 800 Drugs
Drug manufacturers are increasing prices on over 800 drugs by an average of 5.1%, according to a newly released report [...]